Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)
China
· Delayed Price · Currency is CNY 16.05
+0.26 (1.65%)
At close: Mar 10, 2026
SHE:002923 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 1,184 | 1,177 | 1,282 | 1,363 | 1,188 | 1,247 | Upgrade
|
| Other Revenue | 5.53 | 5.53 | 10.06 | 9.01 | 1.98 | 6.07 | Upgrade
|
| Revenue | 1,190 | 1,182 | 1,292 | 1,372 | 1,190 | 1,253 | Upgrade
|
| Revenue Growth (YoY) | -2.76% | -8.48% | -5.85% | 15.32% | -5.01% | -7.89% | Upgrade
|
| Cost of Revenue | 771.62 | 691.9 | 685.03 | 636.32 | 478.84 | 491.79 | Upgrade
|
| Gross Profit | 418.15 | 490.47 | 606.86 | 735.92 | 711.09 | 760.84 | Upgrade
|
| Selling, General & Admin | 331.62 | 310.35 | 392.51 | 459.74 | 475.85 | 528.72 | Upgrade
|
| Research & Development | 102.92 | 129.2 | 127.3 | 92.34 | 84.27 | 93.69 | Upgrade
|
| Other Operating Expenses | 11.99 | 11.27 | 15.46 | 15.25 | 12 | -14.44 | Upgrade
|
| Operating Expenses | 451.96 | 450.95 | 535.43 | 569.89 | 572.6 | 607.28 | Upgrade
|
| Operating Income | -33.81 | 39.52 | 71.43 | 166.02 | 138.49 | 153.55 | Upgrade
|
| Interest Expense | -13.75 | -15.78 | -16.12 | -6.97 | -1.77 | -1.77 | Upgrade
|
| Interest & Investment Income | 1.53 | 1.33 | 2.25 | 1.48 | 2.33 | 6.13 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.85 | 2.85 | 1.76 | 1.3 | -1.34 | -3.03 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.26 | -1.94 | -0.4 | -0.45 | -0.86 | -3.77 | Upgrade
|
| EBT Excluding Unusual Items | -46.44 | 25.98 | 58.92 | 161.38 | 136.84 | 151.11 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0 | 0.01 | -0.36 | -0.02 | -0.02 | 0.01 | Upgrade
|
| Gain (Loss) on Sale of Assets | 17.98 | 18.02 | 27.58 | 0.05 | - | - | Upgrade
|
| Asset Writedown | -19.85 | -0.43 | -0.18 | -0.33 | -0.23 | -2.29 | Upgrade
|
| Other Unusual Items | -3.19 | -0.96 | 0.09 | 19.86 | 15.14 | - | Upgrade
|
| Pretax Income | -51.49 | 42.63 | 86.04 | 180.94 | 151.74 | 148.83 | Upgrade
|
| Income Tax Expense | 0.49 | 2.74 | 19.14 | 25.46 | 11.97 | 12.97 | Upgrade
|
| Net Income | -51.99 | 39.88 | 66.9 | 155.48 | 139.77 | 135.86 | Upgrade
|
| Net Income to Common | -51.99 | 39.88 | 66.9 | 155.48 | 139.77 | 135.86 | Upgrade
|
| Net Income Growth | - | -40.38% | -56.97% | 11.24% | 2.87% | 14.27% | Upgrade
|
| Shares Outstanding (Basic) | 335 | 332 | 334 | 338 | 337 | 334 | Upgrade
|
| Shares Outstanding (Diluted) | 335 | 332 | 334 | 338 | 337 | 334 | Upgrade
|
| Shares Change (YoY) | -2.03% | -0.64% | -1.04% | 0.19% | 0.96% | -1.19% | Upgrade
|
| EPS (Basic) | -0.16 | 0.12 | 0.20 | 0.46 | 0.41 | 0.41 | Upgrade
|
| EPS (Diluted) | -0.16 | 0.12 | 0.20 | 0.46 | 0.41 | 0.41 | Upgrade
|
| EPS Growth | - | -40.00% | -56.52% | 11.03% | 1.89% | 15.64% | Upgrade
|
| Free Cash Flow | 70.36 | 129.94 | -1.85 | -116.75 | -170.58 | -6.4 | Upgrade
|
| Free Cash Flow Per Share | 0.21 | 0.39 | -0.01 | -0.34 | -0.51 | -0.02 | Upgrade
|
| Dividend Per Share | 0.150 | 0.150 | 0.200 | 0.250 | 0.220 | 0.220 | Upgrade
|
| Dividend Growth | -25.00% | -25.00% | -20.00% | 13.74% | - | - | Upgrade
|
| Gross Margin | 35.14% | 41.48% | 46.98% | 53.63% | 59.76% | 60.74% | Upgrade
|
| Operating Margin | -2.84% | 3.34% | 5.53% | 12.10% | 11.64% | 12.26% | Upgrade
|
| Profit Margin | -4.37% | 3.37% | 5.18% | 11.33% | 11.75% | 10.85% | Upgrade
|
| Free Cash Flow Margin | 5.91% | 10.99% | -0.14% | -8.51% | -14.34% | -0.51% | Upgrade
|
| EBITDA | 117.17 | 173.31 | 182.29 | 235.45 | 198.39 | 203.53 | Upgrade
|
| EBITDA Margin | 9.85% | 14.66% | 14.11% | 17.16% | 16.67% | 16.25% | Upgrade
|
| D&A For EBITDA | 150.98 | 133.79 | 110.86 | 69.43 | 59.91 | 49.98 | Upgrade
|
| EBIT | -33.81 | 39.52 | 71.43 | 166.02 | 138.49 | 153.55 | Upgrade
|
| EBIT Margin | -2.84% | 3.34% | 5.53% | 12.10% | 11.64% | 12.26% | Upgrade
|
| Effective Tax Rate | - | 6.44% | 22.25% | 14.07% | 7.89% | 8.71% | Upgrade
|
| Revenue as Reported | 1,190 | 1,182 | 1,292 | 1,372 | 1,190 | 1,253 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.